(Q57839498)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19379122%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

review article

1 reference

title

Spinal cord injury and neural repair: focus on neuroregenerative approaches for spinal cord injury (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19379122%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19379122%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Darryl C Baptiste

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19379122%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Allyson Tighe

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19379122%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

English

0 references

publication date

1 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19379122%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Investigational Drugs

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19379122%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19379122%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19379122%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

663-673

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19379122%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology, demographics, and pathophysiology of acute spinal cord injury

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Targeting recovery: priorities of the spinal cord-injured population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Degenerative and regenerative mechanisms governing spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Microenvironmental determinants of adult neural stem cell proliferation and lineage commitment in the healthy and injured central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Apoptosis after traumatic human spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Neuroprotection and acute spinal cord injury: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Recruitment and early treatment in a multicenter study of acute spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Measurements and recovery patterns in a multicenter study of acute spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Regenerative medicine and the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Bioengineered strategies for spinal cord repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Myelination of congenitally dysmyelinated spinal cord axons by adult neural precursor cells results in formation of nodes of Ranvier and improved axonal conduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Causes and costs of spinal cord injury in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

A comprehensive assessment of the cost of multiple sclerosis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Projected costs of ischemic stroke in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

The strong financial case for regenerative medicine and the regen industry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

How common are the "common" neurologic disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Activation of Rho in the injured axons following spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Neuroprotection mediated by changes in the endothelial actin cytoskeleton.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Administration of the Rho-kinase inhibitor, fasudil, following nitroglycerin additionally dilates the site of coronary spasm in patients with vasospastic angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Oligodendrocyte myelin glycoprotein growth inhibition function requires its conserved leucine-rich repeat domain, not its glycosylphosphatidyl-inositol anchor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Features of skin-coincubated macrophages that promote recovery from spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Spinal cord injury: time to move?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Effects of phosphodiesterase inhibitors on cytokine production by microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Rolipram reduces excitotoxic neuronal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Broad spectrum neuroprotection profile of phosphodiesterase inhibitors as related to modulation of cell-cycle elements and caspase-3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Cytokines and Neurotrophins Interact in Normal and Diseased States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Chondroitin sulfate proteoglycans in spinal cord contusion injury and the effects of chondroitinase treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Chronic ganglioside treatment counteracts the biochemical signs of dopamine receptor supersensitivity induced by chronic haloperidol treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Effects of ganglioside treatments on lesion-induced behavioral impairments and sprouting in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Ganglioside-induced regeneration and reestablishment of axonal continuity in spinal cord-transected rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

Axons from CNS neurones regenerate into PNS grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780902897623

10.1517/13543780902897623

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19379122%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference